Compounds > fludarabine

fludarabine and Liver Neoplasms

fludarabine has been researched along with Liver Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Dong, J; Meng, G; Wei, J; Wu, J; Zhang, H; Zhang, Y; Zuo, S1
Akiyama, M; Goto, H; Hasegawa, D; Honda, T; Kumamoto, T; Ogawa, S; Takagi, M; Terao, YM; Yamaoka, M; Yoshida, K1
Chen, L; Chen, M; Chen, W; Zhang, B; Zhang, L; Zhang, Y1
Azik, F; Emir, S; Erdem, AY; Isik, P; Metin, A; Tavil, B; Tunc, B; Uckan, D1
Altavilla, G; Arrigo, C; Pitini, V1
Boyer, SH; Erion, MD; Linemeyer, DL; MacKenna, DA; Montag, A1
Caracciolo, F; Fazzi, R; Galimberti, S; Petrini, M1
Langiewicz, P; Rzepecki, P; Sarosiek, T; Szczylik, C; Zolnierek, J1
Clausen, NT; Hansen, PB; Larsen, CR1

Trials

1 trial(s) available for fludarabine and Liver Neoplasms

ArticleYear
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
    Neoplasma, 2005, Volume: 52, Issue:3

    Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Transplantation Conditioning; Vidarabine

2005

Other Studies

8 other study(ies) available for fludarabine and Liver Neoplasms

ArticleYear
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
    Cellular oncology (Dordrecht), 2021, Volume: 44, Issue:6

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Immunologic Surveillance; Immunosuppression Therapy; Inflammation; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Oncolytic Viruses; Recombinant Fusion Proteins; Treatment Outcome; Vidarabine; Virus Replication

2021
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
    International journal of hematology, 2022, Volume: 115, Issue:1

    Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; DNA-Binding Proteins; Etoposide; ETS Translocation Variant 6 Protein; Female; Gene Deletion; Humans; Liver Neoplasms; Lymphoma, T-Cell; PAX5 Transcription Factor; Prognosis; Proto-Oncogene Proteins c-ets; Remission Induction; Repressor Proteins; Splenic Neoplasms; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2022
An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: Carcinoma, Hepatocellular; Gene Transfer Techniques; Genes, Transgenic, Suicide; Green Fluorescent Proteins; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Nanostructures; Purine-Nucleoside Phosphorylase; Ultrasonics; Vidarabine

2018
Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.
    Pediatric transplantation, 2013, Volume: 17, Issue:6

    Topics: Antilymphocyte Serum; Blood Platelets; Busulfan; Child; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neutrophils; Remission Induction; Siblings; Transplantation Conditioning; Treatment Outcome; Vidarabine; Wiskott-Aldrich Syndrome

2013
Dasatinib induces a response in chronic lymphocytic leukemia.
    Blood, 2009, Jan-08, Volume: 113, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blood Cell Count; Dasatinib; Female; Fusion Proteins, bcr-abl; Hemorrhage; Humans; Imatinib Mesylate; Jejunal Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction; Rituximab; src-Family Kinases; Thiazoles; Tomography, X-Ray Computed; Vidarabine

2009
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cytarabine; Cytochrome P-450 CYP3A; Drug Delivery Systems; Infusions, Intravenous; Liver; Liver Neoplasms; Male; Mice; Nucleosides; Prodrugs; Thymidine; Tissue Distribution; Vidarabine

2009
Early reappearance of primary solid cancer in patients treated with purine analogs.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Colic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Purines; Remission Induction; Treatment Outcome; Vidarabine

2003
Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
    American journal of hematology, 2002, Volume: 70, Issue:1

    Topics: 2-Chloroadenosine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nucleosides; Vidarabine

2002